Drug development for rare diseases: a case for patient-centricity, equity, and access to clinical trials
Abstract Purpose Clinical trials often represent the only viable treatment option for many rare disease patients. However, these patients face significant barriers to participation, including cognitive and physical limitations, geographic disparities, misdiagnosis, and socioeconomic challenges, with...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-05-01
|
| Series: | Journal of Rare Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s44162-025-00069-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|